A phase 3 open-label, randomized multicenter study to evaluate efficacy and safety of secukinumab in pediatric patients with moderate to severe plaque psoriasis: 24-week results

Nina Magnolo, Külli Kingo, Vivian Laquer, John Browning, Adam Reich, Jacek C. Szepietowski, Deborah Keefe, Rafal Mazur, Prayashi Ghelani, Pascal Forrer, Linda Ann Wraith, Manmath Patekar

Resultado de la investigación: Article › revisión exhaustiva

15 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'A phase 3 open-label, randomized multicenter study to evaluate efficacy and safety of secukinumab in pediatric patients with moderate to severe plaque psoriasis: 24-week results'. En conjunto forman una huella única.

Nursing and Health Professions